Clinical Trials in Los Angeles

Showing 3241-3260 of 8,046 trials

Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis

NCT03737110

The primary objective of this study was to assess the efficacy of rilonacept treatment in participants with recurrent pericarditis.

Recurrent Pericarditis

Kiniksa Pharmaceuticals (UK), Ltd.86 participantsStarted Jan 2019

Los Angeles, California, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +18 more locations

Active Not RecruitingPhase 2< 1 mile

High Dose IL 2 and Entinostat in RCC

NCT03501381

This is a multicenter, randomized, open label study of high dose interleukin 2 vs high dose interleukin 2 plus entinostat in clear cell RCC patients who are candidate for high dose interleukin 2. Patients will be randomized to ARM 1 (high dose interleukin 2 plus entinostat) or ARM 2 (high dose interleukin 2). Subjects will receive up to 3 courses of high dose interleukin 600,000 units/kg administered IV every 8 hrs on Days 1-5 and Days 15-19 (maximum 28 doses) +/- entinostat 5 mg orally given every 2 weeks starting on Day-14, continuously. Tumor response assessment will be performed between HD IL-2 courses.

Renal Cell Carcinoma

Roberto Pili46 participantsStarted May 2018

Los Angeles, California, United States • Chicago, Illinois, United States • Indianapolis, Indiana, United States +2 more locations

Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis

High Dose IL 2 and Entinostat in RCC

Find Trials by Condition in Los Angeles

Development of a Novel Stress Testing Protocol to Define the Relationship Between Coronary Microvascular Dysfunction and Diastology in Women With Angina But No Evidence of Obstructive Coronary Artery Disease

Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"

Real World Evaluation of the Effectiveness of AZD7442 for Prevention of SARS-CoV-2

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

A Comparison of Dynamic Vision & Balance Between College Athletes & Controls

Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis

Intermittent Hypoxia and Caffeine in Infants Born Preterm

Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

Low-Dose Atropine for Treatment of Myopia

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2